Profile for Management of metabolic undesirable era of focused remedies along with immune gate inhibitors within most cancers patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidis (sawcredit55)